Rhenman & Partners Asset Management Ab Top Holdings and 13F Report (2026)

About Rhenman & Partners Asset Management Ab

Investment Activity

Rhenman & Partners Asset Management Ab has $810.49 million in total holdings as of March 31, 2026.
Rhenman & Partners Asset Management Ab owns shares of 86 different stocks, but just 45 companies or ETFs make up 80% of its holdings.
Approximately 19.24% of the portfolio was purchased this quarter.
About 42.25% of the portfolio was sold this quarter.
This quarter, Rhenman & Partners Asset Management Ab has purchased 94 new stocks and bought additional shares in 30 stocks.
Rhenman & Partners Asset Management Ab sold shares of 42 stocks and completely divested from 19 stocks this quarter.

Largest Holdings

Boston Scientific: $39,218,750
Regeneron Pharmaceuticals: $37,163,984
Eli Lilly and Company: $31,010,046
Insmed: $26,123,955
CVS Health: $24,167,430

Largest New Holdings this Quarter

863667101 - Stryker: $15,706,602 Holding
922475108 - Veeva Systems: $14,983,798 Holding
002824100 - Abbott Laboratories: $11,499,040 Holding
946784105 - WAYSTAR HLDG CORP: $8,259,266 Holding
03770N101 - APOGEE THERAPEUTICS INC: $6,312,750 Holding

Largest Purchases this Quarter

Stryker: 47,800 shares (about $15.71M)
Veeva Systems: 85,300 shares (about $14.98M)
Boston Scientific: 193,793 shares (about $12.16M)
Abbott Laboratories: 112,000 shares (about $11.50M)
WAYSTAR HLDG CORP: 342,566 shares (about $8.26M)

Largest Sales this Quarter

COOPER COS INC: 277,500 shares (about $19.84M)
Medtronic: 206,000 shares (about $17.85M)
Align Technology: 91,500 shares (about $15.69M)
Danaher: 81,000 shares (about $15.36M)
Glaukos: 126,000 shares (about $13.57M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
BSX Boston Scientific	$39,218,750	$12,160,511 â–²	44.9%	625,000	4.8%	Medical
REGN Regeneron Pharmaceuticals	$37,163,984	$10,276,112 â–¼	-21.7%	48,100	4.6%	Medical
LLY Eli Lilly and Company	$31,010,046	$7,822,644 â–¼	-20.1%	33,715	3.8%	Medical
INSM Insmed	$26,123,955	$7,550,536 â–²	40.7%	159,760	3.2%	Medical
CVS CVS Health	$24,167,430	$71,820 â–²	0.3%	336,500	3.0%	Medical
GILD Gilead Sciences	$23,379,318	$5,797,792 â–²	33.0%	167,750	2.9%	Medical
TMO Thermo Fisher Scientific	$20,319,850	$3,784,781 â–²	22.9%	41,340	2.5%	Medical
BIIB Biogen	$20,001,303	$3,070,778 â–²	18.1%	109,100	2.5%	Medical
VRTX Vertex Pharmaceuticals	$19,417,792	$4,121,564 â–²	26.9%	43,485	2.4%	Medical
ALHC Alignment Healthcare	$18,561,789	$775,280 â–²	4.4%	1,053,450	2.3%	Medical
ISRG Intuitive Surgical	$16,985,638	$5,141,883 â–¼	-23.2%	36,846	2.1%	Medical
COR Cencora	$16,453,083	$3,455,540 â–¼	-17.4%	52,375	2.0%	Medical
SYK Stryker	$15,706,602	$15,706,602 â–²	New Holding	47,800	1.9%	Medical
ABBV AbbVie	$15,566,847	$8,482,110 â–¼	-35.3%	71,575	1.9%	Medical
VEEV Veeva Systems	$14,983,798	$14,983,798 â–²	New Holding	85,300	1.8%	Medical
MCK McKesson	$14,581,316	$7,571,900 â–¼	-34.2%	16,850	1.8%	Medical
JAZZ Jazz Pharmaceuticals	$14,347,005	$351,633 â–²	2.5%	75,890	1.8%	Medical
GH Guardant Health	$13,393,650	$6,004,050 â–²	81.3%	145,000	1.7%	Medical
NBIX Neurocrine Biosciences	$13,284,793	$3,247,391 â–¼	-19.6%	100,841	1.6%	Medical
EW Edwards Lifesciences	$13,053,040	$2,442,440 â–¼	-15.8%	163,000	1.6%	Medical
MDGL Madrigal Pharmaceuticals	$12,589,454	$2,355,615 â–²	23.0%	24,050	1.6%	Medical
UNH UnitedHealth Group	$12,311,845	$2,543,546 â–¼	-17.1%	45,500	1.5%	Medical
PRCT PROCEPT BioRobotics	$11,879,750	$3,401,360 â–¼	-22.3%	475,000	1.5%	Medical
BMRN BioMarin Pharmaceutical	$11,693,430	$451,920 â–¼	-3.7%	207,000	1.4%	Medical
ABT Abbott Laboratories	$11,499,040	$11,499,040 â–²	New Holding	112,000	1.4%	Medical
ALNY Alnylam Pharmaceuticals	$11,403,435	$3,709,053 â–¼	-24.5%	34,465	1.4%	Medical
RPRX Royalty Pharma	$11,177,010	$1,271,205 â–²	12.8%	233,000	1.4%	Medical
AXSM Axsome Therapeutics	$10,783,476	$8,620,020 â–¼	-44.4%	63,800	1.3%	Medical
NTRA Natera	$10,319,484	$2,219,889 â–²	27.4%	51,600	1.3%	Medical
THC Tenet Healthcare	$10,190,340	$4,246,730 â–¼	-29.4%	54,000	1.3%	Medical
ADPT Adaptive Biotechnologies	$9,993,600	$1,596,200 â–²	19.0%	720,000	1.2%	Medical
LIVN LivaNova	$9,851,800	$2,224,600 â–¼	-18.4%	155,000	1.2%	Medical
ELV Elevance Health	$9,455,825	$5,064,575 â–²	115.3%	32,300	1.2%	Medical
ARWR Arrowhead Pharmaceuticals	$9,060,150		0.0%	144,500	1.1%	Medical
GKOS Glaukos	$9,043,440	$13,565,160 â–¼	-60.0%	84,000	1.1%	Medical
IQV IQVIA	$9,038,620	$4,519,310 â–²	100.0%	53,000	1.1%	Medical
SNDX Syndax Pharmaceuticals	$8,859,280	$2,517,040 â–¼	-22.1%	379,250	1.1%	Medical
MIRM Mirum Pharmaceuticals	$8,554,850	$1,260,987 â–¼	-12.8%	92,605	1.1%	Medical
IDYA IDEAYA Biosciences	$8,513,260	$183,260 â–²	2.2%	255,500	1.1%	Medical
PNTG The Pennant Group	$8,394,162	$2,497,745 â–¼	-22.9%	275,399	1.0%	Medical
NUVL Nuvalent	$8,318,940	$8,416,268 â–¼	-50.3%	81,200	1.0%	Medical
WAYSTAR HLDG CORP	$8,259,266	$8,259,266 â–²	New Holding	342,566	1.0%	COM
ANTERIS TECHNOLOGIES GLOBAL	$7,984,369	$1,110,000 â–²	16.1%	1,438,625	1.0%	COM
MDT Medtronic	$7,798,500	$17,849,900 â–¼	-69.6%	90,000	1.0%	Medical
OSCR Oscar Health	$7,570,200	$4,588,000 â–²	153.8%	660,000	0.9%	Finance
IOVA Iovance Biotherapeutics	$7,214,198	$1,614,600 â–²	28.8%	2,055,327	0.9%	Medical
MLYS Mineralys Therapeutics	$7,126,593	$3,264,345 â–²	84.5%	263,071	0.9%	Medical
IONS Ionis Pharmaceuticals	$6,975,861	$4,925,904 â–¼	-41.4%	92,900	0.9%	Medical
DIANTHUS THERAPEUTICS INC	$6,850,138	$1,426,640 â–¼	-17.2%	81,627	0.8%	COM
BBIO BridgeBio Pharma	$6,727,956	$668,340 â–²	11.0%	90,600	0.8%	Medical
APOGEE THERAPEUTICS INC	$6,312,750	$6,312,750 â–²	New Holding	75,000	0.8%	COM
GPCR Structure Therapeutics	$6,174,420	$939,900 â–¼	-13.2%	128,100	0.8%	Medical
CAH Cardinal Health	$5,705,370	$5,705,370 â–²	New Holding	27,000	0.7%	Medical
EHC Encompass Health	$5,442,320	$8,705,700 â–¼	-61.5%	56,263	0.7%	Medical
AMGN Amgen	$5,348,120	$7,318,480 â–¼	-57.8%	15,200	0.7%	Medical
VKTX Viking Therapeutics	$5,206,400	$2,505,580 â–²	92.8%	160,000	0.6%	Medical
NRIX Nurix Therapeutics	$4,859,250	$3,472,000 â–¼	-41.7%	313,500	0.6%	Medical
ALKS Alkermes	$4,711,720		0.0%	133,250	0.6%	Medical
CRL Charles River Laboratories International	$4,485,000	$690,000 â–²	18.2%	26,000	0.6%	Medical
MLTX MoonLake Immunotherapeutics	$4,464,280	$2,320,680 â–¼	-34.2%	239,500	0.6%	Medical
KRYS Krystal Biotech	$4,307,486	$2,150,514 â–¼	-33.3%	16,675	0.5%	Medical
DOXIMITY INC	$4,282,726	$4,402,348 â–¼	-50.7%	183,808	0.5%	CL A
NEKTAR THERAPEUTICS	$4,245,050	$4,245,050 â–²	New Holding	59,000	0.5%	COM NEW
DNLI Denali Therapeutics	$3,820,800	$1,900,800 â–²	99.0%	199,000	0.5%	Medical
STVN Stevanato Group	$3,776,795	$1,755,201 â–²	86.8%	274,676	0.5%	Medical
RLAY Relay Therapeutics	$3,582,000	$995,000 â–¼	-21.7%	360,000	0.4%	Medical
COOPER COS INC	$3,575,000	$19,841,250 â–¼	-84.7%	50,000	0.4%	COM
SIONNA THERAPEUTICS INC	$3,507,875	$3,507,875 â–²	New Holding	87,500	0.4%	COM
ASND Ascendis Pharma A/S	$3,430,950		0.0%	15,000	0.4%	Medical
DHR Danaher	$3,422,659	$15,357,599 â–¼	-81.8%	18,052	0.4%	Medical
PODD Insulet	$2,937,760	$9,862,480 â–¼	-77.0%	14,000	0.4%	Medical
A Agilent Technologies	$2,849,500	$569,900 â–²	25.0%	25,000	0.4%	Medical
STOK Stoke Therapeutics	$2,702,480	$4,330,480 â–¼	-61.6%	83,000	0.3%	Medical
ESPR Esperion Therapeutics	$2,698,900	$2,698,900 â–²	New Holding	985,000	0.3%	Medical
IMCR Immunocore	$2,584,579	$2,036,753 â–¼	-44.1%	85,724	0.3%	Medical
OCUL Ocular Therapeutix	$2,583,350	$338,800 â–²	15.1%	305,000	0.3%	Medical
STE STERIS	$2,542,995	$1,216,215 â–²	91.7%	11,500	0.3%	Medical
VCEL Vericel	$2,251,900	$1,511,990 â–¼	-40.2%	70,000	0.3%	Medical
KURA Kura Oncology	$2,207,295	$4,882,065 â–¼	-68.9%	271,500	0.3%	Medical
CI Cigna Group	$2,134,000	$8,175,888 â–¼	-79.3%	8,000	0.3%	Medical
BRIGHTSPRING HEALTH SVCS INC	$2,130,500	$6,306,280 â–¼	-74.7%	50,000	0.3%	COM
XENE Xenon Pharmaceuticals	$1,628,200	$6,454,650 â–¼	-79.9%	28,000	0.2%	Medical
ALGN Align Technology	$1,285,725	$15,685,845 â–¼	-92.4%	7,500	0.2%	Medical
NVCR NovoCure	$763,000	$763,000 â–²	New Holding	70,000	0.1%	Medical
ATEC Alphatec	$761,600	$544,000 â–²	250.0%	70,000	0.1%	Medical
CMPX Compass Therapeutics	$608,948	$608,948 â–²	New Holding	115,113	0.1%	Medical
VERA Vera Therapeutics	$0	$21,268,800 â–¼	-100.0%	0	0.0%	Medical
PEN Penumbra	$0	$9,793,665 â–¼	-100.0%	0	0.0%	Medical
APLS Apellis Pharmaceuticals	$0	$9,406,184 â–¼	-100.0%	0	0.0%	Medical
ACLX Arcellx	$0	$8,704,200 â–¼	-100.0%	0	0.0%	Medical
BRKR Bruker	$0	$6,940,010 â–¼	-100.0%	0	0.0%	Computer and Technology
RYTM Rhythm Pharmaceuticals	$0	$3,746,400 â–¼	-100.0%	0	0.0%	Medical
RDNT RadNet	$0	$3,353,450 â–¼	-100.0%	0	0.0%	Medical
INSP Inspire Medical Systems	$0	$3,301,834 â–¼	-100.0%	0	0.0%	Medical
JANX Janux Therapeutics	$0	$3,110,203 â–¼	-100.0%	0	0.0%	Medical
PRVA Privia Health Group	$0	$2,963,750 â–¼	-100.0%	0	0.0%	Medical
CYTK Cytokinetics	$0	$2,819,588 â–¼	-100.0%	0	0.0%	Medical
XNCR Xencor	$0	$2,537,633 â–¼	-100.0%	0	0.0%	Medical
CNTA Centessa Pharmaceuticals	$0	$2,501,000 â–¼	-100.0%	0	0.0%	Medical
TGTX TG Therapeutics	$0	$2,183,583 â–¼	-100.0%	0	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rhenman & Partners Asset Management Ab Top Holdings and 13F Report (2026)

About Rhenman & Partners Asset Management Ab

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rhenman & Partners Asset Management Ab Top Holdings and 13F Report (2026)

About Rhenman & Partners Asset Management Ab

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofRhenman & Partners Asset Management Ab

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools